Search results
Too much data: a burden or a blessing?
Clinical Trials Arena· 7 days agoAs technology evolves and it becomes easier to collect data, the question is now if data collection has tipped too far. Extra data can be incredibly...
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
BioPharma Dive· 10 hours agoCEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive...
Viking shares jump on plans to speed obesity drug into late-stage testing
BioPharma Dive· 13 hours agoThe drug’s advancement continued what one analyst described as a “torrid” pace for Viking’s closely...
Nvidia starts delivering latest chips to Indian partners for AI cloud infra
CNBC Awaaz· 18 hours agoUS-based AI chip giant Nvidia has started delivering its latest chips such as GH200 AI to Indian...
Nanotechnology in medicine: Who are the leading public companies?
Medical Device Network· 3 days agoApplications for nanotechnology in medicine include imaging, diagnosis, or the delivery of drugs...
J&J’s Carvykti to make meteoric rise in multiple myeloma
Clinical Trials Arena· 3 days agoChimeric antigen receptor T-cell (CAR-T) therapies have proven highly effective in...
Exscientia acquires oral CDK7 inhibitor for $20m, plans breast cancer trial
Pharmaceutical Technology· 6 days agoAdditionally, the company says the therapy can overcome common resistance pathways associated with...
Big Pharma is forging an increased number of partnerships with artificial intelligence vendors for...
Clinical Trials Arena· 4 days agoBig Pharma Boosts AI Collaborations for Drug Discovery The pharmaceutical industry is under...
Stocks Hit As Traders Want Signs AI Is Paying Off: Markets Wrap
NDTV Profit· 2 days agoTrack the global equity, currency and commodity markets here. RBC Capital Markets Head of...
Autobahn raises $100M on investor interest in neuropsych drugs
BioPharma Dive· 2 days agoFinney, a former executive at Abide Therapeutics, said the company could seek additional private...